Notably, complement activators MASP2, or mannan-binding lectin serine protease-2, C1S, and the subsequent pro-inflammatory cleavage product C4A all showed elevated levels in all M-LAC fractions among both PCa and BPH patients47. Here, MASP2 is linked to benign prostatic hyperplasia.